Tirzepatide
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Eli Lilly · Phase 2 · Recruiting · Enrollment 1481
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| LY3305677 Obesity ISA OXA1 | n/r | n/r | n/r | n/r | n/r |
| LY3841136 Obesity ISA LAA1 | n/r | n/r | n/r | n/r | n/r |
| LY3841136 Obesity ISA LAA2 | n/r | n/r | n/r | n/r | n/r |
| LY3549492 Obesity ISA GN01 | n/r | n/r | n/r | n/r | n/r |
| LY3549492 Obesity ISA GN02 | n/r | n/r | n/r | n/r | n/r |
| Obesity ISA MC01 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.